NCT07344012 Parental Project Amongst 93 Patients With Turner Syndrome
| NCT ID | NCT07344012 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Turner Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 93 participants |
| Start Date | 2025-11-18 |
| Primary Completion | 2027-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 93 participants in total. It began in 2025-11-18 with a primary completion date of 2027-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim is to describe the parental project, spontaneous pregnancies and pregnancies resulting from egg donation or adoption in women diagnosed with Turner syndrome treated at Strasbourg University Hospitals.
Eligibility Criteria
Inclusion Criteria: * Adult women (≥18 years old) * Treated at Strasbourg University Hospitals for a parental project during the period from January 1, 2009, to December 31, 2019 * Having presented with Turner syndrome confirmed by karyotyping * Having expressed a desire to become a parent during consultation Exclusion Criteria: * No desire to become a parent or missing data * Missing data
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07344012 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Turner Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07344012 currently recruiting?
Yes, NCT07344012 is actively recruiting participants. Contact the research team at thibault.bahougne@chru-strasbourg.fr for enrollment information.
Where is the NCT07344012 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07344012 clinical trial?
NCT07344012 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 93 participants.